P2.01-61 Body Mass Index Over Time Is Associated With Overall Survival in Advanced NSCLC Patients Treated With Immunotherapy.

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1115
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Circulating microRNAs and PD-L1 Tumor Expression Are Associated With Survival in Advanced NSCLC Patients Treated With Immunotherapy: A Prospective Study

Clinical Cancer Research
Cancer ResearchOncology
2019English

Association Between Baseline Body Mass Index and Overall Survival Among Patients Over Age 60 With Acute Myeloid Leukemia

American Journal of Hematology
Hematology
2013English

Increased Body Mass Index Is Associated With Improved Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Oncotarget
Oncology
2016English

MA10.05 Effect of Early Steroids Use in Advanced NSCLC Patients Treated With Immunotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Exercise Restriction Is Not Associated With Increasing Body Mass Index Over Time in Patients With Anomalous Aortic Origin of the Coronary Arteries

Cardiology in the Young
PediatricsCardiologyPerinatologyCardiovascular MedicineMedicineChild Health
2017English

Association of Systemic Inflammation Index and Body Mass Index With Survival in Patients With Renal Cell Cancer Treated With Nivolumab

Clinical Cancer Research
Cancer ResearchOncology
2019English

Predictive Factors Associated With Prolonged Survival in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated With Gefitinib

British Journal of Cancer
Cancer ResearchOncology
2007English

P2.01-88 C-Reactive Protein (CRP) as a Predictive Marker for Survival in Patients With Advanced NSCLC Treated With First Line Pembrolizumab Monotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Table S11: 61 DEmRNAs Associated With Overall Survival in Endometrial Carcinoma

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy